ClinicalTrials.Veeva

Menu

An Innovative Disease-net Management Model for Non-communicable Diseases (SIDERA^B)

D

Don Carlo Gnocchi Onlus Foundation

Status

Unknown

Conditions

Chronic Heart Failure (CHF)
Parkinson Disease (PD)
Chronic Obstructive Pulmonary Disease (COPD)

Treatments

Behavioral: Usual Care Program
Behavioral: SIDERA^B

Study type

Interventional

Funder types

Other

Identifiers

NCT04041193
FdG_SIDERAb_01

Details and patient eligibility

About

The SIDERA^B telerehabilitation system is enabled by a multi-domain, multi-device platform providing at home multi-component rehabilitation, targeting cardiovascular (Chronic Heart Failure, CHF), pulmonary (Chronic Obstructive Pulmonary Disease, COPD) and neurodegenerative (Parkinson Disease, PD) chronic diseases. The rehabilitation program embeds engagement activities for patient and caregiver, to empower appropriation of the SIDERA^B care routines and fuel their well-being resources.

The multidisciplinary layering of SIDERA^B is reflected in the validation protocol including a) clinical and well-being evaluation through a cross-over study confronting usual care with the SIDERA^B activities; b) technological evaluation: Health Technology Assessment for organizational, legal and equity impacts; c) economic evaluation: process mapping and budget impact analysis to define a sustainable reimbursement process for the innovative telerehabilitation pathway.

Enrollment

150 estimated patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. agreement to participate, with the signature of the informed consent form.

  2. availability of a caregiver/study partner, who agrees to support the participant through the SIDERA^B program.

  3. living in one's own home.

  4. clinical diagnosis of Chronic Heart Failure (CHF) and

    1. functional New York Heart Association (NYHA) class II and III with an Ejection Fraction (EF) ≤ 40%
    2. etiology of CHF primitive or post-ischemic.
  5. clinical diagnosis of Chronic Obstructive Pulmonary Disease (COPD) and

    1. COPD diagnosis according to the American Thoracic Society (ATS) and the European Respiratory Society (ERS) criteria with FEV1/FVC ratio <70%
    2. presence of airway limitation according to ATS/ERS and GOLD criteria.
  6. clinical diagnosis of Parkinson Disease (PD) and

    1. PD diagnosis according to the MDS criteria (Postuma et al., 2015)
    2. staging between 1.5 and 3 on the Hoehn & Yahr scale (Goetz et al., 2004)
  7. age between 18 and 85 years.

Exclusion criteria

  1. presence of comorbidities that may prevent you from undertaking a secure home program or determining clinical instability (i.e. severe orthopedic or severe cognitive deficits).
  2. presence of risk conditions for safety under strain in patients with CHF (i.e. severe symptomatic aortic stenosis, evidence of ischemia due to minimal/low-intensity efforts).
  3. COPD patients who do not need rehabilitation treatment (GOLD 1 / A class) or with severe COPD (GOLD 4 / D class)
  4. COPD patients with overlap with other respiratory diseases or not in treatment or in the absence of good ventilatory compensation in the last 6 months
  5. COPD with global respiratory failure with PaCO2> 55 mmHg
  6. PD patients with other neurological pathologies or with severe psychiatric complications
  7. pathological score to a screening test for cognitive impairment (Montreal Cognitive Assessment test - MoCA test <17.54; Conti et al., 2015).

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

150 participants in 2 patient groups

SIDERA^B
Experimental group
Description:
Behavioral: telerehabilitation activities Participants will receive 3months (Chronic Heart Failure) or 4 months (Chronic Obstructive Pulmonary Disease and Parkinson Disease) 5 sessions/week of an individualized telerehabilitation program at home. The sessions will initially be tailored to the patient's baseline characteristics. The exercise program will be charged by the therapist weekly. Each patient's performed session will be reviewed by the therapist.
Treatment:
Behavioral: SIDERA^B
usual care
Active Comparator group
Description:
Behavioral: paper and pencil activities as usual rehabilitation at home Participants will receive 3months (Chronic Heart Failure) or 4 months (Chronic Obstructive Pulmonary Disease and Parkinson Disease) of a usual rehabilitation program.
Treatment:
Behavioral: Usual Care Program

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems